Parallel Advisors, LLC Moderna, Inc. Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
A detailed history of Parallel Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 4,518 shares of MRNA stock, worth $145,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,518
Previous 4,403
2.61%
Holding current value
$145,253
Previous $124,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding MRNA
# of Institutions
858Shares Held
255MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$822 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$802 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$572 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$240 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...